Add to ORKGIntroduction: Triptans have been safely and effectively used in the management of migraine for more than fifteen years, and it seems reasonable to wonder what would be the economic impact of moving a specific triptan to OTC availability. The objective of this study was then to examine the economic impact of payer policies of a triptan Rx-to
Introduction: The appreciable growth in pharmaceutical expenditure has resulted in multiple initiati...
This study examined the use of triptan derivatives in Australia between 1997 and 2015, based on a na...
Introduction: The appreciable growth in pharmaceutical expenditure has resulted in multiple initiati...
Triptans have been safely and effectively used in the management of migraine for more than fifteen y...
INTRODUCTION: Triptans have been safely and effectively used in the management of migraine for more ...
© 2019 ISPOR–The Professional Society for Health Economics and Outcomes Research Background: Migrain...
Objectives: To estimate the burden of migraine in the population of French patients identified as sp...
Triptans are presently a milestone in the treatment of migraine patients. Because of their effective...
Objectives. Pharmacoeconomic studies have not been performed frequently in Japan. This study attempt...
Triptans are presently a milestone in the treatment of migraine patients. Because of their effective...
AbstractObjectivesMigraine is often perceived as a low-impact condition that imposes a limited burde...
Rahul Bhambri,1 Jack Mardekian,1 Larry Z Liu,1,2 Edward Schweizer,3 Elodie Ramos1 1Pfizer, Inc., 2We...
igraine is a chronic, episodic disorder that interrupts the patient’s ability to function and decrea...
This article explores the application of cost-effectiveness analyses to the use of triptanes (5-HT1 ...
The paper analyses the potential economic impact of switching drugs from prescription-only to over t...
Introduction: The appreciable growth in pharmaceutical expenditure has resulted in multiple initiati...
This study examined the use of triptan derivatives in Australia between 1997 and 2015, based on a na...
Introduction: The appreciable growth in pharmaceutical expenditure has resulted in multiple initiati...
Triptans have been safely and effectively used in the management of migraine for more than fifteen y...
INTRODUCTION: Triptans have been safely and effectively used in the management of migraine for more ...
© 2019 ISPOR–The Professional Society for Health Economics and Outcomes Research Background: Migrain...
Objectives: To estimate the burden of migraine in the population of French patients identified as sp...
Triptans are presently a milestone in the treatment of migraine patients. Because of their effective...
Objectives. Pharmacoeconomic studies have not been performed frequently in Japan. This study attempt...
Triptans are presently a milestone in the treatment of migraine patients. Because of their effective...
AbstractObjectivesMigraine is often perceived as a low-impact condition that imposes a limited burde...
Rahul Bhambri,1 Jack Mardekian,1 Larry Z Liu,1,2 Edward Schweizer,3 Elodie Ramos1 1Pfizer, Inc., 2We...
igraine is a chronic, episodic disorder that interrupts the patient’s ability to function and decrea...
This article explores the application of cost-effectiveness analyses to the use of triptanes (5-HT1 ...
The paper analyses the potential economic impact of switching drugs from prescription-only to over t...
Introduction: The appreciable growth in pharmaceutical expenditure has resulted in multiple initiati...
This study examined the use of triptan derivatives in Australia between 1997 and 2015, based on a na...
Introduction: The appreciable growth in pharmaceutical expenditure has resulted in multiple initiati...